Related Experiment Video
Updated: Jan 8, 2026

06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
1.4K
Beyond the binary: Clinico-epidemiological insights from a transgender case series
Vibhu Mendiratta1, Sampurna Dash1
1Department of Dermatology and STD, Lady Hardinge Medical College, New Delhi, India.
Indian Journal of Sexually Transmitted Diseases and AIDS
|December 22, 2025
Summary
Transgender individuals face higher risks for sexually transmitted infections due to factors like early sexual debut. Addressing socioeconomic barriers and improving follow-up care are crucial for better health outcomes in this underserved population.
Area of Science:
- Medical research
- Public health
- Epidemiology
Background:
- Transgender (TG) individuals experience unique healthcare challenges, with elevated vulnerability to sexually transmitted infections (STIs).
- Understanding the specific clinico-epidemiological profile of TG patients is essential for targeted healthcare interventions.
- The Suraksha clinic in Northern India serves a diverse patient population, including TG individuals.
More Related Videos
Related Concept Videos
Sexually Transmitted Infections
858
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
858
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Case Studies
13.2K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
13.2K
Confounding in Epidemiological Studies
554
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
554
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K

